Germany: Inveox raises €17m Series A

The founders of Inveox

Inveox, which has developed a system to digitise, automate and connect pathology laboratories, has raised €17m (US$19m) Series A funding from unnamed investors. Founded in 2017, the Munich based company intends to begin the series-level production of its AI-supported automation system in order to make cancer diagnoses faster and more reliable. “We want to help…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »